Selected Reads

Smartkarma

Equity Bottom-Up

This write up is actually on the Horizon Therapeutics merger arbitrage but because mojoris wrote a survey write up about elevated merger arb spreads on January 30, 2023 and used...<a target="_blank" href="https://www.valueinvestorsclub.com/idea/PROMETHEUS_BIOSCNC_INC/4013654453">Read the article on Value Investor Club »</a>

United States

Ignyta, Inc. is a precision medicine biotechnology company. The Company discovers, acquires and develops new drugs for cancer patients whose tumors harbor specific molecular alterations.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00